Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing.
about
Antibiotic treatment of experimental pneumonic plague in miceDosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms.Bactericidal activity of gentamicin against Enterococcus faecalis in vitro and in vivo.Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulationEfficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.Therapy of intracellular Staphylococcus aureus by tigecyclin.Population pharmacokinetics of gentamicin and dosing optimization for infantsExtended-interval aminoglycoside therapy for adult patients with febrile neutropenia: a systematic reviewDiffusion Retardation by Binding of Tobramycin in an Alginate Biofilm ModelEffects of obesity and sex on antimicrobial pharmacokinetics and acute kidney injury: validation of a preclinical model.Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen.Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?Pharmacokinetics of gentamicin C(1), C(1a), and C(2) in beagles after a single intravenous dose.Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.Extended Interval Tobramycin Pharmacokinetics in a Pediatric Patient With Primary Ciliary Dyskinesia Presenting With an Acute Respiratory Exacerbation.
P2860
Q33691477-AE9C74EC-A1A8-4982-A731-56B5C50B7DE3Q33694513-89F702F8-B438-4DA9-B139-F5CF72DF9C60Q33980188-B057FA76-1B23-411C-A46F-6699E84A0675Q34188814-8FF329FF-D874-4A08-934F-6D62BB41EA84Q34534012-262CD009-011A-4B6D-9334-B6DD786CCFF1Q34759665-45C528F7-14B5-4A53-A94A-CD16B5A20A3CQ34923469-D4D6A973-8269-4355-AEA7-8A5686D549B8Q35089403-83E7FBBE-4A35-4F65-A37D-DDA82D12ABB7Q35996038-0C9EA59A-59D3-4B12-B264-ED33BFCADA56Q36558426-2A312686-5886-481B-8B31-3215F0F0B050Q37389435-78CB4585-89DD-4857-AEA1-22CB33F587B5Q37653435-8DA893FB-A59F-4988-829A-EF3623395BC1Q37695055-BCA9775E-9F5A-44F6-AAD8-384F3A02480EQ39473973-F8B4D464-33EC-4FEB-A69C-EF237163276EQ40224839-3E1F8939-30A0-4BED-9D91-4BBEE377B5CEQ42846052-F746B8DF-DFC5-489A-9637-92468A0873BEQ55015958-2981CB07-0AD5-438C-993D-6A1F235D636D
P2860
Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Pharmacokinetics of gentamicin ...... e-daily aminoglycoside dosing.
@ast
Pharmacokinetics of gentamicin ...... e-daily aminoglycoside dosing.
@en
type
label
Pharmacokinetics of gentamicin ...... e-daily aminoglycoside dosing.
@ast
Pharmacokinetics of gentamicin ...... e-daily aminoglycoside dosing.
@en
prefLabel
Pharmacokinetics of gentamicin ...... e-daily aminoglycoside dosing.
@ast
Pharmacokinetics of gentamicin ...... e-daily aminoglycoside dosing.
@en
P2093
P2860
P356
P1476
Pharmacokinetics of gentamicin ...... ce-daily aminoglycoside dosing
@en
P2093
Bertino JS Jr
Demczar DJ
Nafziger AN
P2860
P304
P356
10.1128/AAC.41.5.1115
P407
P577
1997-05-01T00:00:00Z